カテゴリー： 世界, 医療/バイオ, IMARC

デジタル定量吸入器のグローバル市場：ブランド医薬品、ジェネリック医薬品

【英語タイトル】Digital Dose Inhaler Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが出版した調査資料（IMARC23JLY066）・商品コード：IMARC23JLY066
・発行会社（調査会社）：IMARC
・発行日：2023年7月
・ページ数：150
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

IMARC社では、2022年に29億ドルであった世界のデジタル定量吸入器市場規模が、2023年から2028年の間に年平均成長率14.6％で拡大し、2028年には67億ドルに至ると予想しています。本資料では、デジタル定量吸入器の世界市場を徹底的に調査し、序論、範囲・手法、エグゼクティブサマリー、イントロダクション、種類別（ブランド医薬品、ジェネリック医薬品）分析、製品別（定量吸入器、ドライパウダー吸入器）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの内容を掲載しています。なお、参入企業情報としては、3M Company, AstraZeneca plc, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, H&T Presspart Manufacturing Ltd., Koninklijke Philips N.V., Lupin Limited, Novartis AG, OPKO Health Inc., Propeller Health (ResMed), Sensirion AG Switzerland and Teva Pharmaceutical Industries Ltd.などが含まれています。
・序論
・範囲・手法
・エグゼクティブサマリー
・イントロダクション
・世界のデジタル定量吸入器市場規模：種類別
- ブランド医薬品の市場規模
- ジェネリック医薬品の市場規模
・世界のデジタル定量吸入器市場規模：製品別
- 定量吸入器の市場規模
- ドライパウダー吸入器の市場規模
・世界のデジタル定量吸入器市場規模：地域別
- 北米のデジタル定量吸入器市場規模
- アジア太平洋のデジタル定量吸入器市場規模
- ヨーロッパのデジタル定量吸入器市場規模
- 中南米のデジタル定量吸入器市場規模
- 中東・アフリカのデジタル定量吸入器市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

Market Overview:
The global digital dose inhaler market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2028, exhibiting a growth rate (CAGR) of 14.6% during 2023-2028.

Digital dose inhalers are utilized to provide a simple, accurate, and reliable dose counter, which enables asthma and chronic obstructive pulmonary disease (COPD) patients to track adherence to their therapy. These inhalers comprise sensors that record the time of medication administration and provide a low-dose warning indicator. They also offer a large display for easy accessibility and comprehension by varied patient populations. Nowadays, digital dose inhalers are integrated with Bluetooth technology that assists in pairing with a tablet, smartphone, or computer wirelessly to enable the automatic transfer of data.

Digital Dose Inhaler Market Trends:
A considerable rise in the number of individuals diagnosed with chronic respiratory diseases (CRDs), such as bronchial asthma, lung disorders, pulmonary hypertension (PH) and chronic obstructive pulmonary disease (COPD), represents one of the key factors driving the demand for digital dose inhalers worldwide. Additionally, the risk of developing CRDs is increasing around the world on account of the growing number of tobacco smokers, rising levels of air pollution, and occupational dust exposure in the agriculture, forestry, and mining settings. This, in turn, is bolstering the market growth. Apart from this, governing agencies of numerous countries, along with non-governmental organizations (NGOs), are introducing several programs to spread awareness about CRDs and the available treatments. Moreover, dry powder inhaler (DPI) systems are gaining traction as they target the delivery of fine drug particles to the deeper airways in the lungs. As a result, several manufacturers are offering capsule-based and disposable DPI devices with improved reliability, consistency, and cost-effectiveness, which is driving the market. Furthermore, favorable reimbursement policies available to the patients via government-sponsored plans and individual insurance and employee policies are boosting the treatment rates of respiratory disorders. This, in turn, is projected to stimulate the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global digital dose inhaler market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type and product.

Breakup by Type:
Branded Medication
Generics Medication

Breakup by Product:
Metered Dose Inhaler
Dry Powder Inhaler

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AstraZeneca plc, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, H&T Presspart Manufacturing Ltd., Koninklijke Philips N.V., Lupin Limited, Novartis AG, OPKO Health Inc., Propeller Health (ResMed), Sensirion AG Switzerland and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. What was the size of the global digital dose inhaler market in 2022?
2. What is the expected growth rate of the global digital dose inhaler market during 2023-2028?
3. What are the key factors driving the global digital dose inhaler market?
4. What has been the impact of COVID-19 on the global digital dose inhaler market?
5. What is the breakup of the global digital dose inhaler market based on the type?
6. What is the breakup of the global digital dose inhaler market based on the product?
7. What are the key regions in the global digital dose inhaler market?
8. Who are the key players/companies in the global digital dose inhaler market?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Digital Dose Inhaler Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Branded Medication
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Generics Medication
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product
7.1 Metered Dose Inhaler
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Dry Powder Inhaler
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 3M Company
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 AstraZeneca plc
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 GlaxoSmithKline plc
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.4 Glenmark Pharmaceuticals Limited
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 H&T Presspart Manufacturing Ltd.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Koninklijke Philips N.V.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Lupin Limited
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Novartis AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 OPKO Health Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.10 Propeller Health (ResMed)
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11 Sensirion AG Switzerland
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.12 Teva Pharmaceutical Industries Ltd.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials

Figure 1: Global: Digital Dose Inhaler Market: Major Drivers and Challenges
Figure 2: Global: Digital Dose Inhaler Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Digital Dose Inhaler Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Digital Dose Inhaler Market: Breakup by Type (in %), 2022
Figure 5: Global: Digital Dose Inhaler Market: Breakup by Product (in %), 2022
Figure 6: Global: Digital Dose Inhaler Market: Breakup by Region (in %), 2022
Figure 7: Global: Digital Dose Inhaler (Branded Medication) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Digital Dose Inhaler (Branded Medication) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Digital Dose Inhaler (Generics Medication) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Digital Dose Inhaler (Generics Medication) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Digital Dose Inhaler (Metered Dose Inhaler) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Digital Dose Inhaler (Metered Dose Inhaler) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Digital Dose Inhaler (Dry Powder Inhaler) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Digital Dose Inhaler (Dry Powder Inhaler) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: North America: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: North America: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: United States: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: United States: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Canada: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Canada: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Asia-Pacific: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Asia-Pacific: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: China: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: China: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Japan: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Japan: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: India: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: India: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: South Korea: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: South Korea: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Australia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Australia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Indonesia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Indonesia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Europe: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Europe: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Germany: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Germany: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: France: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: France: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: United Kingdom: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: United Kingdom: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Italy: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Italy: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Spain: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Spain: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Russia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Russia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Latin America: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Latin America: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Brazil: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Brazil: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Mexico: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Mexico: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Middle East and Africa: Digital Dose Inhaler Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Middle East and Africa: Digital Dose Inhaler Market: Breakup by Country (in %), 2022
Figure 63: Middle East and Africa: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Global: Digital Dose Inhaler Industry: SWOT Analysis
Figure 65: Global: Digital Dose Inhaler Industry: Value Chain Analysis
Figure 66: Global: Digital Dose Inhaler Industry: Porter's Five Forces Analysis

★調査レポート[デジタル定量吸入器のグローバル市場：ブランド医薬品、ジェネリック医薬品] (コード：IMARC23JLY066)販売に関する免責事項を必ずご確認ください。
★調査レポート[デジタル定量吸入器のグローバル市場：ブランド医薬品、ジェネリック医薬品]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のデジタル定量吸入器市場2023-2030：製品別（MDI、DPI）、疾患別（喘息、COPD）、種類別（ブランド医薬品、ジェネリック医薬品）、地域別
  • 世界の医薬品市場予測2023-2029：ブランド医薬品、ジェネリック医薬品
  • 医薬品用ガラス製包装のグローバル市場2023～2027：ジェネリック医薬品、ブランド医薬品、生物学的製剤
  • 世界のメラノーマ治療薬市場（2023-2030）：製品別（化学療法、免疫療法）、医薬品種類別（ブランド医薬品、ジェネリック医薬品）、地域別
  • 世界のOTCドライアイ用点眼薬市場（2023-2030）：種類別（ブランド医薬品、ジェネリック医薬品）、製品種類別（防腐剤入り、防腐剤フリー）、粘度別（低粘度、高粘度）、流通チャネル別、地域別
  • 世界のゲムシタビンHCl（塩酸塩）市場2023-2033：種類別（ブランド医薬品、ジェネリック医薬品）、用途別（膵臓がん、乳がん、卵巣がん、非小細胞肺がん（NSCLC））、エンドユーザー別（病院、がんセンター）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆